Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY10.67 CNY
Change Today -0.04 / -0.37%
Volume 55.4M
As of 3:05 AM 06/3/15 All times are local (Market data is delayed by at least 15 minutes).

tianjin tianyao pharm-a (600488) Snapshot

Open
CNY10.75
Previous Close
CNY10.71
Day High
CNY10.98
Day Low
CNY10.35
52 Week High
06/3/15 - CNY10.98
52 Week Low
06/20/14 - CNY4.08
Market Cap
10.3B
Average Volume 10 Days
51.2M
EPS TTM
CNY0.08
Shares Outstanding
960.9M
EX-Date
05/22/15
P/E TM
125.6x
Dividend
CNY0.03
Dividend Yield
0.26%
Current Stock Chart for TIANJIN TIANYAO PHARM-A (600488)

Related News

No related news articles were found.

tianjin tianyao pharm-a (600488) Related Businessweek News

No Related Businessweek News Found

tianjin tianyao pharm-a (600488) Details

Tianjin Tianyao Pharmaceuticals Co., Ltd. researches, manufactures, and sells pharmaceutical APIs in Asia. The company primarily offers corticosteroid, cardio cerebrovascular, and analgesic APIs and formulations. Its product portfolio includes bulk drugs, such as dexamethasone, dexamethasone sodium phosphate, dexamethasone acetate, triamcinlone acetonide acetate, prednisone acetate, prednisone, prednisolone, flucinonide, halcinonide, triamcinolone acetonide, clobetasol propionate, betamethasone, spironolactone, methylprednisolone hemisuccinate, hydrocortisone butyrate, hydrocortisone, hydrocortisone acetate, methylprednisolone, triamcinolone, bucinnazine hydrochloride, and flunarizine hydrochloride. Tianjin Tianyao Pharmaceuticals Co., Ltd. also offers formulations, which include triamcinolone, dexamethasone acetate, prednisone acetate, and methylprednisolone tablets. The company also exports its products. Tianjin Tianyao Pharmaceuticals Co., Ltd. is based in Tianjin, China.

tianjin tianyao pharm-a (600488) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

tianjin tianyao pharm-a (600488) Key Developments

Tianjin Tianyao Pharmaceuticals Co., Ltd. Announces Profit Distribution for 2014, Payable on May 22, 2015

Tianjin Tianyao Pharmaceuticals Co., Ltd. announced implementation of profit distribution for 2014. The company implements the scheme of profit distribution for 2014 as follows: RMB 0.28 (taxes included) for every 10 shares. The record date is May 201, 2015, ex-dividend date is May 22, 2015 and payable on May 22, 2015.

Tianjin Tianyao Pharmaceuticals Co., Ltd. Reports Earnings Results for the First Quarter of 2015

Tianjin Tianyao Pharmaceuticals Co., Ltd. reported earnings results for the first quarter of 2015. For the quarter, basic earnings per share was CNY 0.015, and weighted average return on net assets was 0.60%.

Tianjin Tianyao Pharmaceuticals Co., Ltd. to Report Q1, 2015 Results on Apr 29, 2015

Tianjin Tianyao Pharmaceuticals Co., Ltd. announced that they will report Q1, 2015 results on Apr 29, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
600488:CH CNY10.67 CNY -0.04

600488 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 600488.
View Industry Companies
 

Industry Analysis

600488

Industry Average

Valuation 600488 Industry Range
Price/Earnings 100.0x
Price/Sales 7.4x
Price/Book 4.3x
Price/Cash Flow 127.0x
TEV/Sales 6.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TIANJIN TIANYAO PHARM-A, please visit www.kingyork.biz/tianyaoyaoyeen. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.